<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01893086</url>
  </required_header>
  <id_info>
    <org_study_id>KNC13-029</org_study_id>
    <nct_id>NCT01893086</nct_id>
  </id_info>
  <brief_title>Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy</brief_title>
  <official_title>Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy: a Multi-center, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHA University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHA University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, many gynecologic oncologists proposed that surgeons should consider opportunistic
      salpingectomy to prevent ovarian cancer for all patients undergoing hysterectomy for benign
      disease. However, the safety and the consequences regarding ovarian function after
      salpingectomy have not yet to be established. Therefore, the aim of this randomized
      controlled study is compare the ovarian reserve via anti-Müllerian hormone (AMH) between
      laparoscopic hysterectomy (LH) alone and LH combined with salpingectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ovarian reserve</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>The primary outcome measure was the change of ovarian reserve, determined by the rate of decline in AMH level from before surgery to 3-month post-surgery with the following formula : decline rate (%) = 100 × (preoperative AMH level - postoperative AMH level) ÷ preoperative AMH level.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Benign Uterine Disease</condition>
  <arm_group>
    <arm_group_label>LH alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>LH, laparoscopic hysterectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LH with opportunistic salpingectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LH, laparoscopic hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LH alone</intervention_name>
    <description>LH, laparoscopic hysterectomy</description>
    <arm_group_label>LH alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LH with opportunistic salpingectomy</intervention_name>
    <description>LH, laparoscopic hysterectomy</description>
    <arm_group_label>LH with opportunistic salpingectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women who were planning to undergo laparoscopic hysterectomy for benign uterine
             diseases

          -  women aged between 19 and 52 years

          -  women with regular menstruation (defined as the duration of menstrual cycle between 21
             and 45 days)

          -  women who were appropriated medical status for laparoscopic surgery

        Exclusion Criteria:

          -  any ovarian cysts requiring ovarian surgery

          -  any suspicious findings of malignant diseases

          -  history of prior salpingectomy or salpingo-oophorectomy

          -  pregnant or menopausal status

          -  preoperative serum anti-Müllerian hormone (AMH) &lt; 0.30 ng/mL

          -  use of hormonal treatments in the three months before surgery

          -  any other endocrine disease (such as uncontrolled thyroid dysfunction,
             hyperprolactinemia, or Cushing syndrome)

          -  an inability to understand and provide written informed consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>52 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taejong Song, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kangbuk Samsung Hospital, Seoul, Republic of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Keimyung University School of Medicine</name>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangbuk Samsung Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-746</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHA Gangnam Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-081</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2013</study_first_submitted>
  <study_first_submitted_qc>July 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2013</study_first_posted>
  <last_update_submitted>January 26, 2016</last_update_submitted>
  <last_update_submitted_qc>January 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CHA University</investigator_affiliation>
    <investigator_full_name>Taejong Song</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

